Medicines List

Description

Reverantza contains two substances called olmesartan medoxomil and amlodipine.
Both of these substances help to control high blood pressure.

Olmesartan medoxomil belongs to a group of medicines called ‘angiotensin-II receptor antagonists’ which lower blood pressure by relaxing the blood vessels.

Amlodipine belongs to a group of substances called ‘calcium channel blockers’. Amlodipine stops calcium from moving into the blood vessel wall which stops the blood vessels from tightening thereby also reducing blood pressure.

Indications

Treatment of essential hypertension.
Reverantza is indicated in adult patients whose blood pressure is not adequately controlled on olmesartan medoxomil or amlodipine monotherapy.

Subject to medical prescription.

Concentration and pharmaceutical form: 20 mg/5 mg; 40 mg/5 mg film-coated tablets.

Description

Methylprednisolone-Tchaikapharma belongs to a group of medicines called corticosteroids or steroids.

Indications

Methylprednisolone-Tchaikapharma is used to treat the following conditions:
– Hormonal diseases;
– Rheumatic diseases;
– Collagenosis;
– Skin diseases;
– Allergic conditions;
– Eye diseases;
– Intestinal diseases;
– Pulmonary inflammation;
– Blood disorders;
– Malignancies;
– Swelling;
– Other conditions.

Subject to medical prescription.

Concentration and pharmaceutical form: 40 mg powder and solvent for solution for injection

Description

TromBye contains the active ingredient cilostazol, which belongs to a group of medicines called phosphodiesterase type 3 inhibitors.
Its actions are several and include dilating some blood vessels and reducing the clotting activity (to stick together) of some blood cells, called platelets, in the blood vessels.
TromBye has been prescribed for “intermittent claudication”. It is a spasmodic pain in the legs when walking and is caused by insufficient blood supply to the legs.

Indications

TromBye has been shown to improve the maximum and painless walking distance in patients with intermittent claudication who are painless at rest and without evidence of peripheral tissue necrosis (stage II peripheral arterial disease according to Fontaine).
TromBye is intended for use as a second-line agent in patients in whom lifestyle changes (including smoking cessation and controlled exercise programs) and other appropriate interventions have not sufficiently improved the symptoms of intermittent claudication.

Subject to medical prescription.

Concentration and pharmaceutical form: 100 mg tablets

Description

Tamayra Plus contains three active substances called ramipril, amlodipine and hydrochlorothiazide.

Ramipril belongs to a group of medicines called ACE inhibitors (Angiotensin Converting Enzyme Inhibitors). It works by:
–       Decreasing your body’s production of substances that could raise your blood pressure;
–       Making your blood vessels relax and widen;
–       Making it easier for your heart to pump blood around your body.

Amlodipine belongs to a group of medicines called calcium antagonists. It works by:
–       Relaxing blood vessels, so that blood passes through them more easily.

Hydrochlorothiazide belongs to a group of medicines called “thiazide diuretics” or water tablets. It works by:
–       Increasing the amount of water (urine) you produce. This lowers your blood pressure.

Indications

Tamayra Plus is indicated for:

• the treatment of high blood pressure (hypertension) in adult patients, who are adequately controlled with the individual products given concurrently at the same doses level as in the combination, but as separate tablets.

Subject to medical prescription.

Concentration and pharmaceutical form: 5 mg/5 mg/12,5 mg, 5 mg/5 mg/25 mg, 10 mg/5 mg/25 mg mg hard capsules